Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia
Juvenile myelomonocytic leukemia (JMML) is a typically aggressive myeloid neoplasm of
childhood that is clinically characterized by overproduction of monocytic cells that can …
childhood that is clinically characterized by overproduction of monocytic cells that can …
[HTML][HTML] Molecular targeted therapy and immunotherapy for myelodysplastic syndrome
P Lee, R Yim, Y Yung, HT Chu, PK Yip… - International Journal of …, 2021 - mdpi.com
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal hematological disorder
characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and …
characterized by ineffective hematopoiesis, cytopenia, morphologic dysplasia, and …
[HTML][HTML] Inherited and somatic defects in DDX41 in myeloid neoplasms
Most cases of adult myeloid neoplasms are routinely assumed to be sporadic. Here, we
describe an adult familial acute myeloid leukemia (AML) syndrome caused by germline …
describe an adult familial acute myeloid leukemia (AML) syndrome caused by germline …
Aging drives Tet2+/− clonal hematopoiesis via IL-1 signaling
F Caiado, LV Kovtonyuk, NG Gonullu, J Fullin… - Blood, 2023 - ashpublications.org
Clonal hematopoiesis of indeterminate potential (CHIP), also referred to as aging-related
clonal hematopoiesis, is defined as an asymptomatic clonal expansion of mutant mature …
clonal hematopoiesis, is defined as an asymptomatic clonal expansion of mutant mature …
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
R Piazza, S Valletta, N Winkelmann, S Redaelli… - Nature …, 2013 - nature.com
Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML,
but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and …
but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and …
Somatic SETBP1 mutations in myeloid malignancies
H Makishima, K Yoshida, N Nguyen, B Przychodzen… - Nature …, 2013 - nature.com
Here we report whole-exome sequencing of individuals with various myeloid malignancies
and identify recurrent somatic mutations in SETBP1, consistent with a recent report on …
and identify recurrent somatic mutations in SETBP1, consistent with a recent report on …
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i (17)(q10) …
M Meggendorfer, U Bacher, T Alpermann, C Haferlach… - Leukemia, 2013 - nature.com
Chronic myeloid malignancies are categorized to the three main categories
myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDSs) and MDS/MPN …
myeloproliferative neoplasms (MPNs), myelodysplastic syndromes (MDSs) and MDS/MPN …
[HTML][HTML] SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome
The investigation of genetic forms of juvenile neurodegeneration could shed light on the
causative mechanisms of neuronal loss. Schinzel-Giedion syndrome (SGS) is a fatal …
causative mechanisms of neuronal loss. Schinzel-Giedion syndrome (SGS) is a fatal …
[HTML][HTML] An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of …
In the 2008 WHO classification, chronic myeloid malignancies that share both
myelodysplastic and myeloproliferative features define the myelodysplastic …
myelodysplastic and myeloproliferative features define the myelodysplastic …
SETBP1 is dispensable for normal and malignant hematopoiesis
A Tanaka, K Nishimura, W Saika, A Kon, Y Koike… - Leukemia, 2023 - nature.com
SETBP1 is a potential epigenetic regulator whose hotspot mutations preventing proteasomal
degradation are recurrently detected in myeloid malignancies with poor prognosis. It is …
degradation are recurrently detected in myeloid malignancies with poor prognosis. It is …